Assignee
STEMBIOSYS INC
US4 patents
Top patents by PatentIndex Score
US11220671B2Jan 11, 2022
Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ECM, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds
STEMBIOSYS INC2 citations65
US12454677B2Oct 28, 2025
Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ECM, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds
STEMBIOSYS INC0 citations54
US12270051B2Apr 8, 2025
Amniotic fluid cell-derived extracellular matrix and uses thereof
STEMBIOSYS INC0 citations52
US11180732B2Nov 23, 2021
Amniotic fluid cell-derived extracellular matrix and uses thereof
STEMBIOSYS INC0 citations52